Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A2 | O15244 | 1/20 | 0.36 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20002011 | 1.00 | SLC22A2 (0.36) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL21401948 | 1.00 | SLC22A2 (0.36) | SLC22A2SLC47A1MAPTSMN1; SMN2NPC1 | |
| SCHEMBL20042215 | 0.81 | SMN1; SMN2 (0.34) | SLC22A2SLC47A1MAPTSMN1; SMN2 | |
| SCHEMBL20042213 | 0.81 | SMN1; SMN2 (0.34) | SLC22A2SLC47A1MAPTSMN1; SMN2 | |
| SCHEMBL20042216 | 0.81 | SMN1; SMN2 (0.34) | SLC22A2SLC47A1MAPTSMN1; SMN2 | |
| SCHEMBL191884 | 0.79 | GRIN2D (0.41) | SLC22A2SLC47A1MAPTGRIN2DGRIN3B | |
| SCHEMBL1054419 | 0.79 | — | — | |
| SCHEMBL25237741 | 0.78 | — | — | |
| SCHEMBL31345052 | 0.78 | — | — | |
| SCHEMBL10791429 | 0.75 | SLC22A2 (0.36) | SLC22A2SLC47A1MAPTGRIN2DGRIN3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019183145-A1 | COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC. (US) | 2019-09-26 | — | — | WO | disclosed |
| US-20170253575-A1 | SOLID ACID CATALYST AND METHOD FOR PRODUCING OXIDE | DAICEL CORPORATION (JP) | 2017-09-07 | — | — | US | disclosed |
| US-9447013-B2 | Method for producing oxide | DAICEL CORPORATION (JP) | 2016-09-20 | — | — | US | disclosed |
| US-20160159722-A1 | METHOD FOR PRODUCING OXIDE | DAICEL CORPORATION (JP) | 2016-06-09 | — | — | US | disclosed |
| EP-3023407-A1 | METHOD FOR PRODUCING OXIDE | Daicel Corporation (JP) | 2016-05-25 | — | — | EP | disclosed |
| EP-1238704-B1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEM (JP) | 2015-01-21 | — | — | EP | disclosed |
| EP-2248792-B1 | PROCESS FOR PRODUCTION OF OXYGEN-CONTAINING ORGANIC COMPOUND | DAICEL CHEM (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-1433527-B1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | DAICEL CHEM (JP) | 2013-11-06 | — | — | EP | disclosed |
| US-8410308-B2 | Process for production of oxygen-containing organic compound | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2013-04-02 | — | — | US | disclosed |
| US-7994330-B2 | Oxidizing p-xylene to terephthalic acid using a catalyst having a dicarboximide skeleton; hydrothermally treating the product with hot water, decomposing and removing catalyst impurities | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| EP-1433527-A1 | CATALYSTS COMPRISED OF N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2004-06-30 | — | — | EP | disclosed |
| US-20040053778-A1 | Catalyst comprised of n-substituted cyclic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-18 | — | — | US | disclosed |
| EP-1338336-A1 | CATALYSTS COMPRISING N-SUBSTITUTED CYCLIC IMIDES AND PROCESSES FOR PREPARING ORGANIC COMPOUNDS WITH THE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2003-08-27 | — | — | EP | disclosed |
| US-20030013603-A1 | Catalyst comprising n-substituted cylic imides and processes for preparing organic compounds with the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-16 | — | — | US | disclosed |
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-09-12 | — | — | US | disclosed |
| EP-1238704-A2 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | Daicel Chemical Industries, Ltd. (JP) | 2002-09-11 | — | — | EP | disclosed |
| EP-1055654-A1 | PROCESS FOR THE PREPARATION OF ORGANIC COMPOUNDS WITH IMIDE CATALYSTS | Daicel Chemical Industries, Ltd. (JP) | 2000-11-29 | — | — | EP | disclosed |
| US-4895926-A | Hydroxyethylnorbornene compounds and a process for their preparation | EASTMAN KODAK COMPANY (US) | 1990-01-23 | — | — | US | disclosed |
| US-4855395-A | Hydroxyethylnorbornene compounds and a process for their preparation | EASTMAN KODAK COMPANY (US) | 1989-08-08 | — | — | US | disclosed |
| US-4789602-A | Hydroxyethylnorbornene compounds and a process for their preparation | EASTMAN KODAK COMPANY (US) | 1988-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159722-A1 | METHOD FOR PRODUCING OXIDE | HAO2, NOXO1, NOX4 | SLC22A2 4714/4885SLC47A1 4875/4885MAPT 4291/4885 |
| US-20170253575-A1 | SOLID ACID CATALYST AND METHOD FOR PRODUCING OXIDE | HAO2, HAO1, SCO2 | SLC22A2 2016/4885SLC47A1 3281/4885MAPT 3504/4885 |
| US-20020128149-A1 | Catalyst comprising a cyclic imide compound and process for producing organic compounds using the catalyst | NOX4, POR, NOX1 | SLC22A2 1180/4885SLC47A1 4665/4885MAPT 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.